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ABSTRACT
Background: Diabetic retinopathy (DR) is a microvascular complication of diabetes, which is a cause of 
visual impairment and blindness. Its development and progression have been linked to dyslipidaemia, 
although the link remains inconclusive. Aim: This study aimed to determine the prevalence of 
dyslipidaemia among type 2 diabetic patients with DR in a tertiary setting and to determine the association 
between dyslipidaemia and DR severity. Materials and methods: This was a cross sectional study using 
retrospective data of type 2 diabetic patients attending the opthalmology clinic of a tertiary centre from 
January 2007 to June 2014.  Results of their fasting lipid profile and clinical data were retrieved from 
the  hospital information system. Results: A total of 178 patient’s data were collected. 120 (n=67.4%) 
patients had non-proliferative diabetic retinopathy (NDPR) with moderate NPDR being the most 
prevalent. Dyslipidaemia was noted in 151 (84.8%) of the patients. Patients had a combination of more 
than one abnormality in the lipid profile with increased LDL-cholesterol being the main abnormality.  
Dyslipidaemia was however, not significantly associated with DR severity. Conclusion: Dyslipidaemia 
was highly prevalent in DR patients. The dyslipidaemia was however not associated with severity of DR. 
Keywords: Diabetic retinopathy, Dyslipidaemia, Non-proliferative diabetic retinopathy, 
Proliferative diabetic retinopathy, Type 2 diabetes mellitus  
INTRODUCTION
Diabetic retinopathy (DR) is a well-known microvascular complication of diabetes and a cause of visual impairment 
and blindness worldwide.1-4 DR can be classified into mild, moderate and severe non-proliferative diabetic retinopathy 
(NPDR), proliferative diabetic retinopathy (PDR) and advanced diabetic eye disease (ADED).5 NDPR is characterised 
by formation of microaneurysms and retinal vascular permeability and leakage, and PDR is characterised by 
neovascular proliferation and vitreous haemorrhage.6
In Malaysia, the prevalence of DR in various centres has previously been reported as 44.1%,7 48.6%8 and 51.6%9 
whilst the Malaysian 2007 Diabetic Eye Registry reported a DR prevalence of 36.8%.10 Among well-established risk 
factors for DR are hyperglycaemia and hypertension.3 Clinical practice guidelines from several countries recommend 
that intensive control of high blood glucose and blood pressure not only delay the onset of DR but reduces the rate of 
its progression.11,12,13 Dyslipidaemia has been linked to the pathogenesis of DR, but results from past research showed 
discrepancy on the association of serum lipids with DR severity. Thus, the aim of this study was to determine the 
association between dyslipidaemia and DR severity in type 2 diabetic patients attending the ophthalmology clinic of 
a tertiary centre in Malaysia. 
MATERIALS AND METHODS
This was a cross sectional study using retrospective data retrieved from the electronic medical records of patients 
attending the hospital ophthalmology clinic.   The sample size was calculated using the prevalence of isolated 
dyslipidaemia and combined dyslipidaemia, which were reported as 37.8% and 23.2%, respectively in Type 2 
DM in Malaysia14 taking into account 0.05% unresponsive rate.  Patients fasting serum lipid (FSL) profile results, 
demographics (gender, age and race) and DR severity were obtained. Only patients (18 years old and above) with 
Type 2 DM were included. Patients were classified into mild, moderate and severe NPDR, PDR and Advance Diabetic 
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Eye Disease (ADED). Apart from the standard FSL, which include total cholesterol (TC), triglycerides (TG), LDL-C
and HDL-C, other calculated lipid parameters were used such as non-HDL-C (obtained by subtracting HDL from 
TC), LDL-C/HDL-C and TC/HDL-C. Non-HDL provides a single index of all atherogenic, apoprotein B-containing 
lipoproteins, including LDL, VLDL, IDL, and lipoprotein (a).15 Non-HDL, LDL-C/HDL-C and TC/HDL-C are found 
to be more reliable in predicting cardiovascular disease risk than the standard lipid parameters.15,16 These parameters 
were included in or study as limited research have looked into them with regards to DR. Chi-square test was used to 
determine the association between dyslipidaemia and severity of DR; p value of < 0.05 showed statistical significance. 
This study was approved by the Ethics Committee of the National Medical Research Registry (NMRR-14-452-20733), 
Ministry of Health, and the Ethics Committee of Universiti Putra Malaysia.
RESULTS
A total of 178 patients’ data were obtained. Table 1 shows the demographic characteristics of the patients. There were 
94 (52.8%) males and the remaining 84 (47.2%) were females. Age was categorised into more and less than 60 years 
old, taking 60 as the cut-off age for the definition of elderly in our population. The median age was incidentally 60 years 
old (IQR=12). Majority were Malays (48.3%), followed by Chinese (30.9%) and Indian (20.8%). Majority (67.4%) 
had NPDR with moderate NPDR being the most prevalent. There were 151 (84.8%) patients with dyslipidaemia 
defined as presence of either one or more abnormal results in the lipid profile.  The median parameters of the lipid 
profile are shown in Table 2. Only the median LDL-C and the TC/HDL-C ratio were not within the recommended 
target values for management of dyslipidaemia. There were no significant differences with regards to age (p=0.396), 
gender (p=0.466) and race (p=0.44) with dyslipidaemia or age (p=0.947), gender (p=0.06) and race (p=0.165) with 
DR. 
Table 3 shows the association between the parameters of lipid profile and the severity of DR. There were no 
significant association between dyslipidaemia and severity of DR (p = 0.184). However, in all stages of DR, most 
patients have a combination of more than one abnormality in the parameter of the lipid profile characterised by 
increased LDL-C, low HDL-C and increased triglycerides (TG).  
Table 1: Demographics and clinical characteristic of study population (N=178)
Chracteristics                                   n (%)
Gender
    Male
    Female
Age (years)
    < 60
    ≥ 60
Ethnicity
   Malay
   Chinese
   Indian
Dyslipidaemia
    Present
    Absent
Stages of DR
    Mild NPDR
    Moderate NPDR
    Severe NPDR
    PDR
    ADED
94 (52.8)
84 (47.2)
94 (52.8)
84 (47.2)
86 (48.3)
55 (30.9)
37 (20.8)
151 (84.8)
27   (15.2)
39 (21.9)
50 (28.1)
31 (17.4)
54 (30.3)
4 (2.3)
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Table 2: Lipid profile of study population
Table 3: Association between dyslipidaemia with severity of DR
DISCUSSION
Majority (84.8%) of the patients had dyslipidaemia, which was expected as the overall prevalence of dyslipidaemias 
in type 2 DM in Malaysia was reported as 89.1%.17 The common abnormalities seen were elevated LDL-C, reduced 
HDL-C and increased TG, consistent with diabetic dyslipidaemia.  Majority had a combination of more than one 
abnormalities in their lipid profile. 67.4% were also diagnosed with NPDR. NPDR will progress to PDR if the risks 
for its progression are not controlled.  Identifying the risk factors for DR, especially modifiable ones, is important for 
early intervention and thus slowing the progression of DR. We found no significant association between dyslipidaemia 
and severity of DR which concurred with previous large studies such as Australian Diabetes, Obesity and Lifestyle 
Study (AusDiab)18 and Multi-ethnic study of atherosclerosis (MESA)19 and others.20, 21 Furthermore, studies indicated 
that there was no single lipid marker consistently found to be associated with DR.22 In the Chennai Urban Rural 
Epidemiology Study (CURES), TC was an independent risk factor for DR,23 while Sangkora et. al. 2011 found no 
association with TC but showed that HDL-C level was inversely associated with DR24 In contrast, the Singapore 
Malay Eye Study reported that a higher TC was protective against diabetic retinopathy.2 TG was also shown to be an 
independent risk factor for DR although it did not correlate with DR severity.23 Serum lipids were also thought to have 
Parameter Median (IQR) Min-Max Reference Range
TC (mmol/L) 4.70(1.79) 2.45-10.00 >6.2
TG (mmol/L) 1.56(1.11) 0.48-12.37 >1.7
LDL-C (mmol/L) 2.85(1.5) 0.92-7.22 >2.6
HDL-C (mmol/L) 1.14(0.35) 0.13-2.49 <1.1
Non-HDL-C (mmol/L) 3.62(1.75) 1.33-8.66 ≥3.3
LCL-C/HDL-C 2.66(1.75) 0.71-20.69 ≥3.0
TC/HDL-C 4.34(2.04) 2.07-34.54 ≥4.0
TC: total cholesterol; TG: triglyceride; LDL-C: low density lipoprotein cholesterol; HDL-C: high 
density lipoprotein cholesterol
Mild 
NPDR
n(%)
Moderate 
NPDR
n(%)
Severe NPDR
n(%)
PDR
n(%)
ADED
n(%)
TOTAL
N (%)
TC 
> 6.2mmol/L
TG 
> 1.7mmol/L
LDL-C 
> 2.6mmol/L
HDL-C
< 1.1mmol/L
Non-HDL-C
 ≥ 3.35mmol/L
LDL-C/HDL-C 
≥ 3.0mmol/L
TC/HDL-C 
≥ 4.0mmol/L
Total
X2
p-value
3(7.7)
18(46.2)
22(56.4)
 
13(33.3)
24(61.5)
13(33.3)
18(46.2)
39
1.397
10(20.0)
19(38.0)
28(56.0)
25(50.0)
29(53.0)
18(36.0)
34(68.0)
50
0.021
5(16.0)
18(58.1)
20(64.5)
22(71.0)
25(80.6)
16(51.6)
25(80.6)
31
3.898
0.184
15(27.8)
21(38.9)
30(55.6)
22(40.7)
29(53.7)
20(37.0)
31(57.4)
54
0.951
1(25.0)
1(25.0)
3(75.0)
1(25.0)
3(75.0)
2(50.0)
3(75.0)
4
0.700
34(19.1)
77(43.26)
103(57.9)
83(46.6)
110(61.8)
69(38.8)
111(62.3)
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stronger association with clinically significant macular oedema (CSME) rather than DR.  Although DR and CSME 
share similar pathogenesis, it has been suggested that the association of serum lipids with DR differed from CSME due 
to lack of significant association of serum lipids with DR.20 In this study, patients with diabetic macular oedema were 
not included as its association with dyslipidaemia has already been established in previous research.25,26
Recently, serum apolipoprotein-A1 (ApoA1) and apolipoprotein B (ApoB) were reported to have better association 
with DR progression and severity than the traditional lipid markers, suggesting that future research should include 
these biomarkers.24,27 ApoA1 was inversely related while ApoB and ApoB/ApoA1 ratio was positively associated with 
DR severity.24 This is further supported by clinical evidence that lipid lowering therapies are effective in preventing 
progression of DR, independent of effects on traditional serum lipid markers.28 Thus, in future, apolipoprotein might 
be used as an indicator of DR severity and response to treatment. 
Our study had a few limitations. Being a cross-sectional study and using retrospective data of a single centre may 
not be representative of the whole diabetic population with DR in Malaysia. Other factors which may affect severity 
of DR such as glycaemic control, duration of diabetes and the use of lipid-lowering medications were not taken into 
consideration. This was due to lack of recorded clinical data as most of the patients were followed up in various 
primary care centres for their diabetic management.
CONCLUSION
The prevalence of dyslipidaemia in patients with DR was highly prevalent with most patients having more than 
one abnormal parameter in the lipid profile. Raised LDL-C was the main abnormality seen. Dyslipidaemia was not 
associated with the severity of DR in our population of type 2 DM patients. 
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